EU mid-market update: Red across global markets but bond selloff at forefront of damage; Macro focus on US inflation on Wed as banks kick off earnings season.

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK ... on stocks such as Oxford BioMedica, Zealand Pharma, and Galapagos.

Learn More Pharmaceutical giant GSK is pushing the boundaries of what generative AI can achieve in healthcare areas like scientific literature review, genomic analysis and drug discovery.

Chairman & CEO. “Faisal has a proven track record in integrating cutting-edge science with practical, evidence-base PHILADELPHIA, October 24, 2024--New data for AREXVY, GSK’s RSV vaccine ...

GSK announced that its monoclonal antibody, Nucala (mepolizumab), has been approved in China for treating adults with chronic rhinosinusitis with nasal polyps (CRSwNP), a condition affecting 30 ...

GSK (GSK) announced that the US Food and Drug ... syringe presentation of Shingrix for the prevention of shingles. The new prefilled syringe removes the need to reconstitute separate vials prior ...

The company noted that the new presentation has the same composition as the reconstituted vaccine. The submission is based on data demonstrating comparability between the two. GSK's shingles ...

A new solar farm is set to power a major manufacturing ... The provision of renewable energy solutions to GSK demonstrates a long-term commitment to the site and the region." ...

Multiple countries, including New Zealand and Australia, are trying to use tax and competition rules to stem the growing ...

To know the 4 risks we have identified for GSK visit our risks dashboard for free. Most companies need money -- from somewhere -- to grow their profits. That cash can come from retained earnings, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...